Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic NPC”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Testing effectiveness (Phase 2)UnknownNCT04586088
What this trial is testing

Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more
Sun Yat-sen University 58
Testing effectiveness (Phase 2)UnknownNCT04955886
What this trial is testing

Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 14
Large-scale testing (Phase 3)Study completedNCT03924986
What this trial is testing

Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Cancer
BeiGene 263
Testing effectiveness (Phase 2)Study completedNCT02794077
What this trial is testing

Cyclophosphamide for Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Undifferentiated CarcinomaStage IV Nasopharyngeal Undifferentiated Carcinoma
The University of Hong Kong 56
Testing effectiveness (Phase 2)Study completedNCT00096512
What this trial is testing

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Testing effectiveness (Phase 2)Study completedNCT00030576
What this trial is testing

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Health Network, Toronto 51
Large-scale testing (Phase 3)Looking for participantsNCT06976190
What this trial is testing

MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Lepu Biopharma Co., Ltd. 446
Testing effectiveness (Phase 2)Study completedNCT00603915
What this trial is testing

Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT00055913
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00630149
What this trial is testing

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 35
Testing effectiveness (Phase 2)WithdrawnNCT03390738
What this trial is testing

Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
The University of Hong Kong
Testing effectiveness (Phase 2)Study completedNCT02269943
What this trial is testing

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Celgene 36
Testing effectiveness (Phase 2)UnknownNCT02878889
What this trial is testing

A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03813394
What this trial is testing

Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC

Who this might be right for
Locally Recurrent CancerMetastatic Nasopharyngeal Cancer
National University Hospital, Singapore 48
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)UnknownNCT04917770
What this trial is testing

The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
West China Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT07070479
What this trial is testing

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen 208
Testing effectiveness (Phase 2)Active Not RecruitingNCT05513573
What this trial is testing

Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Shanghai Henlius Biotech 75
Testing effectiveness (Phase 2)UnknownNCT03130270
What this trial is testing

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guilin Medical University, China 29
Next Page